Ozempic is suddenly a household brand name, akin to Aleve, Advil, or Nyquil. Many people are calling Ozempic, and other drugs like it, “miracle drugs.” Ozempic and Mounjaro are part of a class of drugs called GLP-1 receptor agonists (GLP-1s for short). Ozempic was approved by the F.D.A. in 2017, while Mounjaro, Ozempic’s primary competitor, was approved in 2022. Both were approved in the U.S. by the F.D.A. to help lower blood sugar. Soon after the drugs… Read more »